Doctor Raquel Lopez Vilella
Hospital Universitario y Politecnico La Fe, Valencia (Spain)
Member of:
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Mortality after the first hospital admission for acute heart failure. de novo vs. acutely decompensated heart failure with reduced ejection fraction
Event: Heart Failure 2023
Topic: Clinical
Session: ePosters in acute heart failure 4
Is the benefit of treating iron deficiency greater in acute heart failure with renal dysfunction?
Event: Heart Failure 2023
Topic: Pharmacotherapy
Session: ePosters in acute heart failure 5
Therapeutic approach in heart failure with poor diuretic response. Peripheral ultrafiltration vs. conventional treatment
Event: Heart Failure 2023
Topic: Nonpharmacological Treatment
Session: ePosters in acute heart failure 2
Long-term study of prevalence and evolution of tricuspid regurgitation after orthotopic heart transplantation
Event: Heart Failure 2022
Topic: Heart Transplantation
Session: Heart Failure ePosters - focus on Chronic Heart Failure 7
Tratamiento en hospital de día.
Event: Heart Failure 2022
Topic: Chronic Heart Failure
Session: Local Track - Programas de Insuficiencia Cardiaca Comunitaria, una historia de éxito
Variation in diuretic requirement after peripheral ultrafiltration in heart failure with diuretic resistance
Event: Heart Failure 2022
Topic: Nonpharmacological Treatment
Session: Heart Failure ePosters - focus on Acute Heart Failure
Changes over the years in the indication for heart-lung transplantation in Spain
Event: Heart Failure 2022
Topic: Heart Transplantation
Session: Heart Failure ePosters - focus on Chronic Heart Failure 2
Variations in the medical treatment of heart failure during admission for decompensation
Event: Heart Failure 2022
Topic: Pharmacotherapy
Session: Heart Failure ePosters - focus on Chronic Heart Failure 2
Experience with COVID-19 heart transplant patients in a tertiary hospital
Event: Heart Failure 2021
Topic: Heart Transplantation
Session: Chronic Heart Failure - Treatment 1
Preliminary experience on the usefulness of immunoglobulin A as a biomarker in patients with decompensated heart failure
Event: Heart Failure 2021
Topic: Biomarkers
Session: ePoster session
ESC 365 is supported by
